Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DESOXIMETASONE vs DEUCRAVACITINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DESOXIMETASONE vs DEUCRAVACITINIB: Safety Overview

Metric DESOXIMETASONE DEUCRAVACITINIB
Total FAERS Reports 11,635 2,386
Deaths Reported 3,743 36
Death Rate 32.2% 1.5%
Hospitalizations 4,664 121
Average Patient Age 45.8 yrs 56.8 yrs
% Female Patients 97.8% 63.8%
FDA Approval Date Approved Prior to Jan 1, 1982 Sep 9, 2022
Manufacturer A-S Medication Solutions E.R. Squibb & Sons, L.L.C.
Route TOPICAL ORAL
Marketing Status Discontinued Prescription